Siga announces preclinical oncology research collaboration with bioarchitech

Investigating tpoxx® in combination with bioarchitech's oncolytic vaccinia immunotherapy platform investigating tpoxx® in combination with bioarchitech's oncolytic vaccinia immunotherapy platform

SIGA Ratings Summary

SIGA Quant Ranking